Skip to content
Menu

This Abbott Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor 8 hours ago

MarketsTrading IdeasPre-Market OutlookNewsAnalyst RatingsUpgrades

Wall Street analysts upgraded RGA, BRO, ABT, FMX and MRSH, raising price targets and outlooks across reinsurance, insurance, healthcare and beverages.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • UBS analyst Michael Ward upgraded Reinsurance Group of America, Incorporated (NYSE:RGA) from Neutral to Buy and raised the price target from $236 to $325. Reinsurance Group closed at $265.55 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Elyse Greenspan upgraded Brown & Brown Inc (NYSE:BRO) from Equal-Weight to Overweight and boosted the price target from $68 to $82. Brown & Brown shares closed at $72.90 on Wednesday. See how other analysts view this stock.
  • Leerink Partners analyst Mike Kratky upgraded Abbott Laboratories (NYSE:ABT) from Market Perform to Outperform and announced a $124 price target. Abbott closed at $104.48 on Wednesday. See how other analysts view this stock.
  • Barclays analyst Benjamin Theurer upgraded Fomento Economico Mexcn SAB de CV ADR (NYSE:FMX) from Equal-Weight to Overweight and announced a $155 price target. Fomento Economico shares closed at $127.74 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Elyse Greenspan upgraded Marsh & McLennan Companies Inc (NYSE:MRSH) from Equal-Weight to Overweight and raised the price target from $197 to $235. Marsh closed at $205.43 on Wednesday. See how other analysts view this stock.

Considering buying ABT stock? Here’s what analysts think:

Photo via Shutterstock

Read at benzinga.com